Whitehawk Therapeutics (WHWK) Other Non Operating Income (2016 - 2026)
Whitehawk Therapeutics (WHWK) reported Other Non Operating Income of $1.3 million for Q1 2026, down 98.49% year-over-year from $88.2 million in Q1 2025, and up 335.41% on a QoQ basis from $305000.0 in Q4 2025.
Whitehawk Therapeutics (WHWK) has 8 years of Other Non Operating Income data on file, last reported at $1.3 million in Q1 2026.
- Quarterly Other Non Operating Income fell 98.49% year-over-year to $1.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.8 million (down 97.97% YoY) and the FY2025 annual result came in at $302000.0, up 7650.0% from the prior year.
- Other Non Operating Income rose to $1.3 million in Q1 2026 per WHWK's latest filing, from $305000.0 in the prior quarter.
- Across five years, Other Non Operating Income topped out at $88.2 million in Q1 2025 and bottomed at -$4.7 million in Q4 2023.
- The 5-year median for Other Non Operating Income is $562000.0 (2022), against an average of $6.3 million.
- The widest annual swing landed in 2023, when Other Non Operating Income plunged 317.9%; it then jumped 7725.0% in 2025.
- Tracing WHWK's Other Non Operating Income over 5 years: stood at $2.2 million in 2022, then sank by 317.9% to -$4.7 million in 2023, then surged by 99.92% to -$4000.0 in 2024, then jumped by 7725.0% to $305000.0 in 2025, then soared by 335.41% to $1.3 million in 2026.
- Per Business Quant, the three latest WHWK Other Non Operating Income figures stand at $1.3 million (Q1 2026), $305000.0 (Q4 2025), and $158000.0 (Q2 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Whitehawk Therapeutics | 312.26 Mn | 189.22 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.33 Mn |
| Dec 31, 2025 | 305,000.00 |
| Jun 30, 2025 | 158,000.00 |
| Mar 31, 2025 | 88.23 Mn |
| Dec 31, 2024 | -4,000.00 |
| Sep 30, 2024 | -1,000.00 |
| Mar 31, 2024 | 1.22 Mn |
| Dec 31, 2023 | -4.72 Mn |
| Sep 30, 2023 | 1.55 Mn |
| Jun 30, 2023 | 1.57 Mn |
| Mar 31, 2023 | 1.60 Mn |
| Dec 31, 2022 | 2.17 Mn |
| Sep 30, 2022 | 562,000.00 |
| Jun 30, 2022 | 100,000.00 |
| Mar 31, 2022 | -43,000.00 |
| Dec 31, 2021 | -45,000.00 |
| Sep 30, 2021 | 223,000.00 |
| Jun 30, 2021 | 196,000.00 |
| Mar 31, 2021 | -1.39 Mn |
| Dec 31, 2020 | -383,000.00 |
| Sep 30, 2020 | -228,000.00 |
| Mar 31, 2016 | 997.00 |